vs
Side-by-side financial comparison of Inogen Inc (INGN) and STRATASYS LTD. (SSYS). Click either name above to swap in a different company.
STRATASYS LTD. is the larger business by last-quarter revenue ($137.0M vs $68.6M, roughly 2.0× Inogen Inc). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs -2.2%). STRATASYS LTD. produced more free cash flow last quarter ($2.5M vs $-1.9M). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs -7.4%).
Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.
Stratasys, Ltd. is an American-Israeli manufacturer of 3D printers, software, and materials for polymer additive manufacturing as well as 3D-printed parts on-demand. The company is incorporated in Israel. Engineers use Stratasys systems to model complex geometries in a wide range of polymer materials, including: ABS, polyphenylsulfone (PPSF), polycarbonate (PC), polyetherimide and Nylon 12.
INGN vs SSYS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $68.6M | $137.0M |
| Net Profit | — | $-55.6M |
| Gross Margin | 51.4% | 41.0% |
| Operating Margin | -13.6% | -16.6% |
| Net Margin | — | -40.6% |
| Revenue YoY | 3.4% | -2.2% |
| Net Profit YoY | — | -109.0% |
| EPS (diluted) | $-0.26 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $68.6M | — | ||
| Q3 25 | $79.1M | $137.0M | ||
| Q2 25 | $79.2M | $138.1M | ||
| Q1 25 | $68.5M | $136.0M | ||
| Q4 24 | $66.3M | — | ||
| Q3 24 | $74.9M | $140.0M | ||
| Q2 24 | $74.4M | $138.0M | ||
| Q1 24 | $63.1M | $144.1M |
| Q4 25 | — | — | ||
| Q3 25 | $-5.3M | $-55.6M | ||
| Q2 25 | $-4.2M | $-16.7M | ||
| Q1 25 | $-6.2M | $-13.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-6.0M | $-26.6M | ||
| Q2 24 | $-5.6M | $-25.7M | ||
| Q1 24 | $-14.6M | $-26.0M |
| Q4 25 | 51.4% | — | ||
| Q3 25 | 52.2% | 41.0% | ||
| Q2 25 | 52.2% | 43.1% | ||
| Q1 25 | 53.1% | 44.3% | ||
| Q4 24 | 54.7% | — | ||
| Q3 24 | 55.2% | 44.8% | ||
| Q2 24 | 57.4% | 43.8% | ||
| Q1 24 | 54.5% | 44.4% |
| Q4 25 | -13.6% | — | ||
| Q3 25 | -9.0% | -16.6% | ||
| Q2 25 | -7.7% | -12.0% | ||
| Q1 25 | -11.2% | -9.1% | ||
| Q4 24 | -17.2% | — | ||
| Q3 24 | -10.4% | -18.2% | ||
| Q2 24 | -9.5% | -18.9% | ||
| Q1 24 | -25.8% | -17.0% |
| Q4 25 | — | — | ||
| Q3 25 | -6.7% | -40.6% | ||
| Q2 25 | -5.2% | -12.1% | ||
| Q1 25 | -9.0% | -9.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | -8.0% | -19.0% | ||
| Q2 24 | -7.5% | -18.6% | ||
| Q1 24 | -23.1% | -18.0% |
| Q4 25 | $-0.26 | — | ||
| Q3 25 | $-0.20 | — | ||
| Q2 25 | $-0.15 | — | ||
| Q1 25 | $-0.25 | — | ||
| Q4 24 | $-0.41 | — | ||
| Q3 24 | $-0.25 | — | ||
| Q2 24 | $-0.24 | — | ||
| Q1 24 | $-0.62 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.7M | $71.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $192.2M | $852.5M |
| Total Assets | $298.6M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $103.7M | — | ||
| Q3 25 | $106.5M | $71.5M | ||
| Q2 25 | $103.7M | $71.1M | ||
| Q1 25 | $118.9M | $70.1M | ||
| Q4 24 | $113.8M | — | ||
| Q3 24 | $105.7M | $64.0M | ||
| Q2 24 | $97.9M | $70.9M | ||
| Q1 24 | $107.4M | $91.1M |
| Q4 25 | $192.2M | — | ||
| Q3 25 | $197.2M | $852.5M | ||
| Q2 25 | $199.5M | $902.4M | ||
| Q1 25 | $198.0M | $784.8M | ||
| Q4 24 | $173.9M | — | ||
| Q3 24 | $185.4M | $831.8M | ||
| Q2 24 | $187.6M | $850.5M | ||
| Q1 24 | $191.9M | $866.1M |
| Q4 25 | $298.6M | — | ||
| Q3 25 | $307.0M | $1.1B | ||
| Q2 25 | $312.0M | $1.1B | ||
| Q1 25 | $308.4M | $1.0B | ||
| Q4 24 | $296.2M | — | ||
| Q3 24 | $306.2M | $1.1B | ||
| Q2 24 | $308.9M | $1.1B | ||
| Q1 24 | $315.6M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-943.0K | $6.9M |
| Free Cash FlowOCF − Capex | $-1.9M | $2.5M |
| FCF MarginFCF / Revenue | -2.8% | 1.8% |
| Capex IntensityCapex / Revenue | 1.4% | 3.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-13.7M | $-11.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-943.0K | — | ||
| Q3 25 | $2.2M | $6.9M | ||
| Q2 25 | $4.3M | $-1.1M | ||
| Q1 25 | $-16.8M | $4.5M | ||
| Q4 24 | $-3.0M | — | ||
| Q3 24 | $7.0M | $-4.5M | ||
| Q2 24 | $6.7M | $-2.4M | ||
| Q1 24 | $-4.7M | $7.3M |
| Q4 25 | $-1.9M | — | ||
| Q3 25 | $1.6M | $2.5M | ||
| Q2 25 | $3.7M | $-8.4M | ||
| Q1 25 | $-17.1M | $789.0K | ||
| Q4 24 | $-3.3M | — | ||
| Q3 24 | $5.3M | $-6.3M | ||
| Q2 24 | $6.6M | $-4.9M | ||
| Q1 24 | $-6.1M | $5.0M |
| Q4 25 | -2.8% | — | ||
| Q3 25 | 2.0% | 1.8% | ||
| Q2 25 | 4.6% | -6.1% | ||
| Q1 25 | -24.9% | 0.6% | ||
| Q4 24 | -5.0% | — | ||
| Q3 24 | 7.1% | -4.5% | ||
| Q2 24 | 8.9% | -3.6% | ||
| Q1 24 | -9.6% | 3.5% |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 0.7% | 3.2% | ||
| Q2 25 | 0.9% | 5.3% | ||
| Q1 25 | 0.4% | 2.8% | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 2.2% | 1.3% | ||
| Q2 24 | 0.1% | 1.8% | ||
| Q1 24 | 2.1% | 1.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INGN
| Other | $36.1M | 53% |
| Non Us | $32.5M | 47% |
SSYS
Segment breakdown not available.
